| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |